BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9824154)

  • 21. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perifosine, a novel alkylphospholipid, induces p21(WAF1) expression in squamous carcinoma cells through a p53-independent pathway, leading to loss in cyclin-dependent kinase activity and cell cycle arrest.
    Patel V; Lahusen T; Sy T; Sausville EA; Gutkind JS; Senderowicz AM
    Cancer Res; 2002 Mar; 62(5):1401-9. PubMed ID: 11888912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties.
    Bearss DJ; Lee RJ; Troyer DA; Pestell RG; Windle JJ
    Cancer Res; 2002 Apr; 62(7):2077-84. PubMed ID: 11929828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
    Seoane J; Le HV; Massagué J
    Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of cyclin-dependent kinase activity during mitotic exit and maintenance of genome stability by p21, p27, and p107.
    Chibazakura T; McGrew SG; Cooper JA; Yoshikawa H; Roberts JM
    Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4465-70. PubMed ID: 15070741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53-induced p21 controls DNA replication.
    Waga S; Li R; Stillman B
    Leukemia; 1997 Apr; 11 Suppl 3():321-3. PubMed ID: 9209378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Control of p53 and p21 (WAF1) expression during unilateral ureteral obstruction.
    Morrissey JJ; Ishidoya S; McCracken R; Klahr S
    Kidney Int Suppl; 1996 Dec; 57():S84-92. PubMed ID: 8941927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair.
    Li R; Waga S; Hannon GJ; Beach D; Stillman B
    Nature; 1994 Oct; 371(6497):534-7. PubMed ID: 7935768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of colon cancer cell proliferation by the dietary compound conjugated linoleic acid is mediated by the CDK inhibitor p21CIP1/WAF1.
    Lim DY; Tyner AL; Park JB; Lee JY; Choi YH; Park JH
    J Cell Physiol; 2005 Oct; 205(1):107-13. PubMed ID: 15880444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cleavage of CDK inhibitor p21(Cip1/Waf1) by caspases is an early event during DNA damage-induced apoptosis.
    Gervais JL; Seth P; Zhang H
    J Biol Chem; 1998 Jul; 273(30):19207-12. PubMed ID: 9668108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human cyclin C protein is stabilized by its associated kinase cdk8, independently of its catalytic activity.
    Barette C; Jariel-Encontre I; Piechaczyk M; Piette J
    Oncogene; 2001 Feb; 20(5):551-62. PubMed ID: 11313987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct interaction of Gadd45 with PCNA and evidence for competitive interaction of Gadd45 and p21Waf1/Cip1 with PCNA.
    Chen IT; Smith ML; O'Connor PM; Fornace AJ
    Oncogene; 1995 Nov; 11(10):1931-7. PubMed ID: 7478510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased p21 levels are required for efficient restart of DNA synthesis after S phase block.
    Gottifredi V; McKinney K; Poyurovsky MV; Prives C
    J Biol Chem; 2004 Feb; 279(7):5802-10. PubMed ID: 14597617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo ubiquitination and proteasome-mediated degradation of p53(1).
    Maki CG; Huibregtse JM; Howley PM
    Cancer Res; 1996 Jun; 56(11):2649-54. PubMed ID: 8653711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination.
    Sheaff RJ; Singer JD; Swanger J; Smitherman M; Roberts JM; Clurman BE
    Mol Cell; 2000 Feb; 5(2):403-10. PubMed ID: 10882081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proteasome-mediated degradation of BRCA1 protein in MCF-7 human breast cancer cells.
    Choi YH
    Int J Oncol; 2001 Oct; 19(4):687-93. PubMed ID: 11562742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteasome inhibitors induce p53/p21-independent apoptosis in human glioma cells.
    Wagenknecht B; Hermisson M; Eitel K; Weller M
    Cell Physiol Biochem; 1999; 9(3):117-25. PubMed ID: 10494025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell attachment to the extracellular matrix induces proteasomal degradation of p21(CIP1) via Cdc42/Rac1 signaling.
    Bao W; Thullberg M; Zhang H; Onischenko A; Strömblad S
    Mol Cell Biol; 2002 Jul; 22(13):4587-97. PubMed ID: 12052868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nuclear translocation of p21(WAF1/CIP1) protein prior to its cytosolic degradation by UV enhances DNA repair and survival.
    Lee JY; Kim HS; Kim JY; Sohn J
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1361-6. PubMed ID: 19895794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma.
    Chiarle R; Budel LM; Skolnik J; Frizzera G; Chilosi M; Corato A; Pizzolo G; Magidson J; Montagnoli A; Pagano M; Maes B; De Wolf-Peeters C; Inghirami G
    Blood; 2000 Jan; 95(2):619-26. PubMed ID: 10627471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.